The Only Anticoagulant Product Approved by the United States Food & Drug Administration

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, USP (2.13% free citrate ion), is a sterile, non-pyrogenic solution. ACD-A is the only anticoagulant product approved by the United States Food & Drug Administration (FDA) for the use in Autologous PRP Systems for the preparation of Platelet-Rich Plasma (PRP).

Procedures

  • Multiple

Application

  • Autologous PRP

Product Features

Technology

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, USP (2.13% free citrate ion), is a sterile, non-pyrogenic solution.

Citrate-based anticoagulants prevent the coagulation of blood by virtue of the citrate ion's ability to chelate ionized calcium present in the blood to form a non-ionized calcium-citrate complex.

Benefits

Anticoagulant approved by the FDA

  • ACD-A is the only anticoagulant product approved by the United States Food and Drug Administation (FDA) for the use in Autologous PRP Systems for the preparation of Platelet-Rich Plasma (PRP).

Safety Information

Indications 

  • Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A) is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous Platelet-Rich Plasma (PRP) Systems in production of PRP.

Warnings and Contraindications

  • ACD-A is not for direct intravenous infusion.

Adverse Reactions

  • Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Additional Information